FDA guidance on cardiovascular risk of antidiabetic therapies: one decade later

Research output: Contribution to journalLetter, comment or opinionpeer-review

Fingerprint

Dive into the research topics of 'FDA guidance on cardiovascular risk of antidiabetic therapies: one decade later'. Together they form a unique fingerprint.

Medicine & Life Sciences